Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer

For locally advanced and metastatic head and neck squamous cell carcinoma (HNSCC), the current clinical use of Cetuximab in chemo/radiotherapy protocols is often associated to severe systemic toxicity. Here we report in vitro data in human FaDu pharynx SCC cells, showing that inactive concentrations...

Descripción completa

Detalles Bibliográficos
Autores principales: Vesci, Loredana, Milazzo, Ferdinando Maria, Anastasi, Anna Maria, Petronzelli, Fiorella, Chiapparino, Caterina, Carollo, Valeria, Roscilli, Giuseppe, Marra, Emanuele, Luberto, Laura, Aurisicchio, Luigi, Pacello, Maria Lucrezia, Spagnoli, Luigi Giusto, De Santis, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808042/
https://www.ncbi.nlm.nih.gov/pubmed/26575422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808042/
https://www.ncbi.nlm.nih.gov/pubmed/26575422

Ejemplares similares